{Reference Type}: Journal Article
{Title}: Versatility of the medial corticoperiosteal flap: from recalcitrant non-unions up to large bony defects.
{Author}: Roger de Oña I;Garcia Villanueva A;Garcia Lopez JI;Garcia de Lucas F;
{Journal}: Arch Orthop Trauma Surg
{Volume}: 144
{Issue}: 6
{Year}: 2024 Jun 21
{Factor}: 2.928
{DOI}: 10.1007/s00402-024-05351-0
{Abstract}: <B>BACKGROUND: </B>Reconstructive microsurgery techniques using vascularized bone grafts have revolutionized the treatment of complex cases associated with recalcitrant non-unions or osteomyelitis. The medial femoral corticoperiosteal flap (MFCP flap) has emerged as a valuable option in bone reconstruction. Its clinical applications have been extended over the years considering this flap from non-unions with minimal bone lost, up to large intercalary defects of the upper and lower extremities. This article aims to present the clinical applications and outcomes of the MFCP flap in various reconstructive scenarios.<BR><B>METHODS: </B>Seventy-nine patients with persistent non-union and bone defects of the upper and lower limb were evaluated from June 2008 to October 2020. All of them were reconstructed with a corticoperiosteal flap from the medial femoral condyle in our hospital. Previous procedures, bone gap and type of flap used were recorded. Postoperative functional status was assessed with time of bone healing, complications and clinical final outcome.<BR><B>RESULTS: </B>Radiological evidence of bone union was observed at 4.09 months (range 2-9). Healing rate was 97% with periosteal corticocancellous flaps (PCC flaps) and 93% with corticoperiosteal flaps (CP flaps). Average follow-up was 14.5 months (range 5-28). There were no significant donor site complications.<BR><B>CONCLUSIONS: </B>The MFCP flap offers a versatile and reliable option for bone reconstruction. Its ability to provide vascularized bone tissue with low morbidity enhances the healing process and improves outcomes. The MFCP flap has been increasing its applications and it serves as a valuable option in the treatment of recalcitrant non-unions or bony defects irrespective of site and size up to 5 cm in the upper and lower extremities.